ArticleFrontiers in neurology2019
The Outcome of Status Epilepticus and Long-Term Follow-Up.
Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Treatment outcome and its predictors among patients with status epilepticus in Africa: A systematic review and meta-analysis.Exploratory research in clinical and social pharmacy · 2026Review
- Evaluating Treatment Dynamics in Refractory Status Epilepticus: A Retrospective Observational Cohort Study.The Neurohospitalist · 2026Article
- A nomogram model for predicting seizure control in status epilepticus: development and risk factor analysis.Frontiers in neurology · 2026Article
- Mortality in older adults with epilepsy: An understudied entity.Epilepsia open · 2025Review
- The Prognostic Factors in Children With Status Epilepticus and Status Epilepticus Severity Score Scales.Behavioural neurology · 2025Article
- Intracerebroventricular administration of the exercise hormone irisin or acute strenuous exercise alleviates epileptic seizure-induced neuroinflammation and improves memory dysfunction in rats.BMC neuroscience · 2024Article
- Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database.Frontiers in pharmacology · 2024Article
- Article
- Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study.Discover oncology · 2023Article
- Understanding the Influence of Hospital Volume on Inpatient Outcomes Following Hospitalization for Status Epilepticus.Neurocritical care · 2023Article
- The clinical analysis of new-onset status epilepticus.Epilepsia open · 2022Article
- Status epilepticus: review on diagnosis, monitoring and treatment.Arquivos de neuro-psiquiatria · 2022Article
- Epidemiology and Risk Factors of Convulsive Status Epilepticus Patients Admitted in the Emergency Department of Tertiary Hospital in Mogadishu, Somalia.International journal of general medicine · 2022Article
- The Efficacy and Safety Profile of Generic Intravenous Levetiracetam in a Real-World Setting.Current therapeutic research, clinical and experimental · 2021Article
- Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.Molecular neurobiology · 2020Article
- Successful treatment of drug-resistant status epilepticus in an adult patient with Mowat-Wilson syndrome: A case report.Epilepsy & behavior reports · 2020Article
- Reported Incidence of Cluster Seizures in Persons with Epilepsy Experience from Two Tertiary Hospitals in Enugu Southeast Nigeria.Nigerian medical journal : journal of the Nigeria Medical AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.